Cargando…
Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review
CONTEXT: Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs) are assessed in clinical trials as a measure of efficacy. However, it remains unclear to what extent current PRO instruments capture symptoms...
Autores principales: | Colomer-Lahiguera, Sara, Bryant-Lukosius, Denise, Rietkoetter, Sarah, Martelli, Lorraine, Ribi, Karin, Fitzpatrick-Lewis, Donna, Sherifali, Diana, Orcurto, Angela, Juergens, Rosalyn, Eicher, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364679/ https://www.ncbi.nlm.nih.gov/pubmed/32676785 http://dx.doi.org/10.1186/s41687-020-00210-z |
Ejemplares similares
-
CN26 Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland: A qualitative study
por: Colomer-Lahiguera, S., et al.
Publicado: (2020) -
Experiences of people affected by cancer during the outbreak of the COVID-19 pandemic: an exploratory qualitative analysis of public online forums
por: Colomer-Lahiguera, Sara, et al.
Publicado: (2021) -
CN31 Oncology nurses' experience in German and French-speaking Switzerland during the COVID-19 pandemic
por: Eicher, M., et al.
Publicado: (2020) -
Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills
por: Howell, Doris, et al.
Publicado: (2023) -
Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland
por: Colomer-Lahiguera, Sara, et al.
Publicado: (2023)